Wilson Sonsini Goodrich & Rosati advised Totient on the deal. AbSci, the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, announced the acquisition...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Goodwin Procter advised Graphite Bio on the deal. Graphite Bio, Inc., a clinical-stage, next-generation gene editing company focused on therapies...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Pinsent Masons advised 4D pharma plc on the deal. 4D pharma plc, a Leeds, UK-based pharmaceutical company leading the development...
You must be a Standard 1 Year member to access this content.
